ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NSCI Netscientific Plc

68.50
0.00 (0.00%)
07 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Netscientific Plc LSE:NSCI London Ordinary Share GB00BN4R5Q82 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 68.50 67.00 70.00 68.50 67.00 68.50 3,493 08:00:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 1M -3.09M -0.1312 -5.22 16.15M
Netscientific Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker NSCI. The last closing price for Netscientific was 68.50p. Over the last year, Netscientific shares have traded in a share price range of 49.00p to 75.50p.

Netscientific currently has 23,574,303 shares in issue. The market capitalisation of Netscientific is £16.15 million. Netscientific has a price to earnings ratio (PE ratio) of -5.22.

Netscientific Share Discussion Threads

Showing 1701 to 1722 of 5825 messages
Chat Pages: Latest  77  76  75  74  73  72  71  70  69  68  67  66  Older
DateSubjectAuthorDiscuss
30/4/2020
08:46
Wakey wakey hands of snakey ?
the stigologist
30/4/2020
03:05
$PDSB news overnight
the stigologist
29/4/2020
22:56
You a crazy fool This was a spike like PYC did today Both willNeed to fall back to sub 2p levels before the pumpers will find aNew angle to pump the stock
iamgreat1
29/4/2020
17:35
My average is 6.5p. Now I'm going to try and hold for the expected 30p, minimum.
clive talking
29/4/2020
13:27
Bizarre - people who wouldn't buy at 6p are now paying 9.35p for the same

Wonder if it's iamgreat1 buying back his soiled shorts?

topnotch
29/4/2020
12:01
nice cash position:

Cash and cash equivalents at HQ and portfolio companies of £3.5 million

euclid5
29/4/2020
09:26
escapetohome >> for someone who has no vested interest here, you seem to waste a disproportionate amount of time posting pointless, negative comments about it
topnotch
28/4/2020
13:50
Well that's good to hear.

Wouldn't be at all surprised if this one quickly rallies 10p from here..

clive talking
28/4/2020
13:44
But im really pleased with my avacta holding,the gains on that have balanced out my covid loss.

So overall my portfolio is showing no overall loss at the moment, due to covid.

escapetohome
28/4/2020
13:42
£0 clive.

Ive never shorted an individual stock.

I bought some vilx before the covid outbreak and made around 180% , when that black swan event happened.

But i havent got back in to that yet.

There is some unusual strength in these markets.

escapetohome
28/4/2020
13:27
Will you tell us how much you've won from your bet shorting this then?
clive talking
28/4/2020
10:30
Now all you need is delisting RNS.

And this will be a pittance.

escapetohome
28/4/2020
10:29
Oh dear!!!

Looks my like TIMBER advice was spot on.

Very very apt.

escapetohome
28/4/2020
09:31
Silly games going on here...
garth
27/4/2020
14:57
Interesting they actually mentioned ProAxsis covid19 opportunities
the stigologist
24/4/2020
17:23
Feels like the Virus has left
rosco230667
24/4/2020
15:59
Shame as empty bubbles like this keep rising and real investments like UFO alien metals are stagnant
akmal101
24/4/2020
15:17
Iamgreat reported for deramping. Report derampers to below
adnexal schevsur
24/4/2020
11:02
:0)

It is new for me. Been doing some digging the last couple of days.

So, OT then, but not far off:

Cash burn rate isn't too bad.

Their "NXP002" is based on Tranilast. Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases. Covid-19 activates NLRP3 - acutely in a number of patients.

Ergo...

Maybe 2=2=4, or maybe it doesn't.

I have taken a position on the basis that it often does. No comment in that regard from the company yet. The underlying business looks undervalued to me with the low burn giving reassurance. Makes it all look a bit of a no-brainer in the wider context of my portfolio.

That makes NSCI and NFX my bio/pharma positions.

Not advice - DYOR.

G.

garth
24/4/2020
10:52
NFX never rated it. Seems far too promotional. A turn off.
the stigologist
24/4/2020
10:52
Jonah someone who brings bad luck
the stigologist
24/4/2020
10:51
NFX looks interesting chartwise - will add to my watchlist

Thanks - and for the explanation also

topnotch
Chat Pages: Latest  77  76  75  74  73  72  71  70  69  68  67  66  Older